74 results
Page 3 of 4
424B5
3dezd 8dfy6kt
2 Aug 19
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
wxn9lj4a4v8v ier
2 Jul 19
Viking Therapeutics Appoints Kathy Rouan, Ph.D., to Board of Directors
4:15pm
424B5
xrbqky
21 Sep 18
Prospectus supplement for primary offering
4:16pm
8-K
EX-99.1
z100uolw4fst9wewb
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
424B5
i95kg6dl034d 7nl23sg
19 Sep 18
Prospectus supplement for primary offering
4:27pm
8-K
EX-99.1
338 fapdn
12 Jun 18
Viking Therapeutics Announces Closing of Public Offering of Common Stock
7:10am
424B5
ul4 bk30q2r1rvptq7ef
7 Jun 18
Prospectus supplement for primary offering
5:13pm
8-K
EX-99.1
l89a6jynead74pk9uhkw
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
424B5
vpi yh0mlln5p9
6 Jun 18
Prospectus supplement for primary offering
4:11pm